Kromek Group Appoints Claire Burgess as CFO to Support Strategic Growth

PUBLISHED: May 08 2025 @ 03:05 | Comments (0) | More info about Fiona Craig

Kromek Group plc (LSE:KMK) has announced a key leadership transition, naming Claire Burgess as its new Chief Financial Officer and Company Secretary. She succeeds Paul Farquhar, who is stepping down after his tenure with the company. Burgess brings over a decade of senior financial experience in the engineering and technology sectors, positioning her well to help drive Kromek’s strategic ambitions in high-tech innovation and global expansion.

Her appointment is seen as a timely move to enhance financial oversight and operational execution, as the company focuses on scaling its core technologies in radiation detection and bio-detection.

Business Outlook and Performance

Despite recent partnerships—such as a promising collaboration with Siemens Healthineers—Kromek faces ongoing financial headwinds, especially around profitability and cash flow. The company’s valuation remains under pressure, and technical indicators suggest mixed momentum with notable resistance levels. Nevertheless, the leadership change is expected to strengthen internal capabilities and support the firm’s path toward long-term growth.

About Kromek Group plc

Based in County Durham, UK, Kromek Group is a specialist in advanced detection solutions for medical imaging, security, and industrial applications. With operations across the UK and the US, the company develops technologies for disease diagnosis, nuclear detection, and biosecurity. In addition to providing components for high-resolution imaging and contamination monitoring, Kromek is advancing airborne pathogen detection systems as part of its broader CBRN (chemical, biological, radiological, and nuclear) detection suite.

Average Daily Trading Volume: 1,204,246 shares
Technical Sentiment Indicator: Sell
Market Capitalization: £36.89 million

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.